Serum NfL levels were also considerably higher in the SCA3 population compared to controls, and increased serum NfL levels were observed in manifest SCA3 subjects and preclinical SCA3 individuals. The gene discussed is NEFL; the disease is Spinocerebellar ataxia type 3.